Filter
1881
Text search:
drug
trial
Featured
Recommendations
184
New Publications
323
Language
Document type
No document type
1055
Guidelines
322
Studies & Reports
315
Manuals
82
Fact sheets
35
Strategic & Response Plan
30
Training Material
17
Situation Updates
9
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
95
Global
71
South Africa
56
Western and Central Europe
41
Kenya
29
Africa
29
Uganda
27
Ethiopia
25
Eastern Europe
23
Russia
23
Tanzania
22
Nigeria
21
Zambia
21
Liberia
20
Ukraine
19
Sierra Leone
17
Zimbabwe
17
Latin America and the Carribbean
17
Ghana
15
Nepal
15
Malawi
15
Philippines
14
Bangladesh
13
Brazil
13
Rwanda
12
Myanmar / Burma
11
Colombia
9
South–East Asia Region
9
South Sudan
8
Cambodia
8
Mozambique
8
Namibia
8
East and Southern Africa
8
Asia
8
Germany
7
Indonesia
7
Lesotho
7
West and Central Africa
7
Congo, Democratic Republic of
6
USA
6
Thailand
6
Middle East and North Africa
5
Tajikistan
5
Guinea
4
Argentina
4
Eswatini/ Swaziland
4
Vietnam
4
Senegal
3
Cameroon
3
Syria
3
Sudan
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Georgia
3
Burkina Faso
2
Guinea-Bissau
2
Haiti
2
China
2
North Macedonia
2
Hungary
2
Botswana
2
Bolivia
2
Mexico
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Kyrgyzstan
2
Jamaica
2
Spain
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Pakistan
1
Jordan
1
Lebanon
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Ecuador
1
Bhutan
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Iran
1
Kazakhstan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
466
Clinical Guidelines
248
Public Health
92
Women & Child Health
81
Key Resources
26
Pharmacy & Technologies
18
Capacity Building
11
Toolboxes
HIV
302
Mental Health
273
TB
221
COVID-19
127
NTDs
119
NCDs
62
Ebola & Marburg
44
AMR
42
Pharmacy
40
Malaria
39
Caregiver
21
Disability
18
Refugee
18
Planetary Health
15
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
9
Cholera
6
Polio
6
2.0 Rapid Response
6
Conflict
5
Natural Hazards
4
Zika
4
Specific Hazards
3
Social Ethics
3
Summary of current WHO recommendations and guidance on programmatic approaches
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi
...
Evidence from Low and Middle Income Countries
War Trauma Foundation strengthens mental health care and psychosocial support through capacity building and development and dissemination of expertise through the implementation of programmes in (post) conflict areas. We develop and evaluate new methods in close cooperation with (local) partner orga
...
The importance of growing up in a nurturing and supportive family environment cannot be underestimated. Raising children in a warm, loving environment sets them on a positive developmental trajectory for later life success (Biglan et al, 2012). Conversely, children raised in homes with inconsistent
...
Suicide is largely preventable. Unlike for many other health issues, the tools to significantly reduce the most tragic loss of life by suicide are available. With collective action to acknowledge and address this serious problem, as well as commitment to effective interventions, supported by politic
...
Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
The WHO mhGAP programme’s existing guidelines recommend that either structured brief psychological treatm
...
Accessed Febr. 6, 2020
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
J. European Academy of Dermatology and Venereology, 4 August 2014
4th edition